Comparison of nicardipine and esmolol for intraoperative blood pressure control during awake deep brain stimulation surgery: a retrospective study
- 30 September 2025
- journal article
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 16 (3) , 532-539
Abstract
Aim: Awake deep brain stimulation (DBS) surgery requires the patient to remain conscious for optimal electrode placement through intraoperative neurophysiological monitoring. However, hypertension during awake DBS poses significant clinical challenges, potentially compromising surgical accuracy and patient safety. Nicardipine and esmolol are both used for intraoperative blood pressure control, but their comparative efficacy in awake DBS remains unclear. The aim of this study was to compare the effectiveness of nicardipine and esmolol in controlling intraoperative blood pressure during awake DBS surgery under monitored anesthesia care. Material and Methods: This retrospective study evaluated patients who underwent awake DBS surgery under MAC between January 2020 and April 2025. Forty adult patients experiencing intraoperative hypertension (systolic arterial pressure [SAP] ≥150 mmHg) were included and divided into two groups based on the antihypertensive agent administered: nicardipine (n = 20) or esmolol (n = 20). Hemodynamic parameters, antihypertensive requirements, and intraoperative complications were compared between the groups. Results: Mean intraoperative SAP was significantly lower in the nicardipine group compared to the esmolol group (121.9 ± 2.6 mmHg vs. 127.9 ± 3.5 mmHg, p = 0.04). Although the frequency of hypertensive episodes tended to be lower with nicardipine, this did not reach statistical significance (15.9% ± 3.6 vs. 26.1% ± 4.1, p = 0.21). Esmolol resulted in significantly lower heart rates (69.2 ± 2.8 bpm vs. 87.9 ± 2.0 bpm, p = 0.01) but required higher doses of rescue antihypertensives (glyceryl trinitrate: 53.1 ± 5.8 mg vs. 25.8 ± 1.2 mg, p < 0.001). No major intraoperative complications or conversions to general anesthesia occurred in both groups. Conclusions: Nicardipine provided more effective and stable intraoperative blood pressure control than esmolol during awake DBS surgery, reducing the need for additional antihypertensive medications. Both agents were safely administered without compromising patient cooperation or neurophysiological monitoring. Therefore, nicardipine may be preferable due to the less need for rescue antihypertensive treatment.Keywords
This publication has 19 references indexed in Scilit:
- Comparison of Esmolol and Nicardipine treatment in hypertensive acute ıschemic stroke patientsScientific Reports, 2025
- Elevated blood pressure after craniotomy: A prospective observational studyJournal of Critical Care, 2020
- Clinical analysis and treatment of symptomatic intracranial hemorrhage after deep brain stimulation surgeryBritish Journal Of Neurosurgery, 2016
- Microelectrode recording (MER) findings during sleep–awake anesthesia using dexmedetomidine in deep brain stimulation surgery for Parkinson’s diseaseClinical Neurology and Neurosurgery, 2016
- Nicardipine Is Superior to Esmolol for the Management of Postcraniotomy Emergence HypertensionAnesthesia & Analgesia, 2015
- The autonomic effects of deep brain stimulation—a therapeutic opportunityNature Reviews Neurology, 2012
- Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesisNeurobiology of Disease, 2012
- Intra-Operative Deep Brain Stimulation of the Periaqueductal Grey Matter Modulates Blood Pressure and Heart Rate Variability in HumansNeuromodulation: Technology at the Neural Interface, 2010
- Blood Pressure Management in Acute Intracerebral HemorrhageStroke, 2004
- Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metaboliteClinical Pharmacology & Therapeutics, 1983